Technology applicable to a wide range of drug delivery needs
DelSiTech is the leading technology specialist in biodegradable silica-based controlled release of small molecule drugs, biopharmaceuticals and viral vectors. We focus on parenteral and local administration of drug products.
Products with high commercial potential – DelSiTech’s own drug product for high unmet clinical and commercial needs.
Innovative delivery technology – Silica-based drug delivery for controlled release of small molecules and bioparmaceuticals.
New nanotech solutions in drug delivery – DelSiTech is a world technology leader in advanced biodegradable silica based controlled release materials.
The natural solution for your drug delivery needs – We help you to get the most out of your innovations.
DelSiTech currently holds technology collaboration and licensing agreements with AstraZenega, Anticancer Bioscience, Bayer Pharma AG, Innovare R&D, Iveric Bio, Optifye Therapeutics, Unitaid, MedImmune, Visus Therapeutics and Solani Therapeutics Ltd and evaluation agreements with several pharma, animal health and biotech companies.